Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
ARAY · against 18 other Healthcare companies of similar size
Ranked #14 of 19 · scores higher than 28% of peers
Bars: peers in each 10-point band of the growth score1 peers with a growth score of 10–19, including ARAY · Click a bar to see the companies
Mainly because of its revenue growth and 3-year revenue growth, which are weaker than most Healthcare peers.
| Metric | ARAY | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 20 reported | -12.3% | 2.5% | 32% | 33% | |
| Earnings per share growthHigher is better · 0 reported | Not reported | — | — | — | 33% |
| 3-year revenue growthHigher is better · 18 reported | -3.5% | 0.7% | 35% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 9M USD | 99 | 45 | |
| 2 | 298M SEK (≈$30M) | 94 | 48 | |
| 3 | 276M SEK (≈$28M) | 93 | 48 | |
| 4 | 250M SEK (≈$25M) | 92 | 44 | |
| 4 | 12M USD | 92 | 38 | |
| 10 | 3.5B JPY (≈$24M) | 39 | 48 | |
| 11 | 27M USD | 35 | 24 | |
| 12 | 25M GBP (≈$33M) | 30 | 31 | |
| 13 | 17M USD | 21 | 18 | |
| 14 | 17M USD | 14 | 16 | |
| 15 | 31M USD | 8 | ||
| 16 | 110M HKD (≈$14M) | 2 | 28 | |
| 16 | 390.5B IDR (≈$24M) | 2 | 8 | |
| 18 | 3.4B JPY (≈$23M) | 0 | 5 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score